# Processa Pharmaceuticals, Inc.: Form 8-K, filed May 26, 2021

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: 8-K
- Filed: 2021-05-26
- Accepted by EDGAR: May 26, 2021, 06:15 ET
- Period: 2021-05-25
- Accession: 0001493152-21-012907
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000149315221012907/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000149315221012907/

## Items reported

- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000149315221012907/form8-k.htm

Filed May 26, 2021.
Source: SEC EDGAR, the filing index for accession 0001493152-21-012907. Last ingested by Listed: Nov 14, 2026, 23:30 ET. No prices; not investment advice.
